Related Experiment Video

Updated: Apr 27, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

13.6K

Epidemiology and clinical management of pulmonary hypertension in children

Hongfang Jin1, Jinyan Yang, Qingyou Zhang

  • 1Department of Pediatrics, Peking University First Hospital, Beijing, China.

Korean Circulation Journal
|September 15, 2012
PubMed

Insights

Pediatric pulmonary hypertension (PH) is a dangerous condition with high mortality. This review comprehensively covers PH definition, classification, epidemiology, prognosis, and treatment to improve understanding and care.

Area of Science:

  • Pediatric Cardiology
  • Pulmonology
  • Clinical Medicine

Background:

  • Pulmonary hypertension (PH) is a serious hemodynamic syndrome marked by elevated pulmonary artery pressure and resistance.
  • It can lead to right ventricular failure and mortality, particularly in children where it's less common but highly hazardous.
  • High mortality rates in pediatric PH necessitate improved understanding and management strategies.

Purpose of the Study:

  • To provide a comprehensive overview of pediatric pulmonary hypertension.
  • To review recent research on the diagnosis and treatment of pediatric PH.
  • To enhance the global understanding of this critical pediatric condition.

Main Methods:

  • Systematic review of recently published research on pediatric pulmonary hypertension.
  • Analysis of data from global registry organizations.
  • Synthesis of information regarding PH definition, classification, epidemiology, prognosis, and treatment.

Main Results:

  • Pulmonary hypertension presents with increased pulmonary artery pressure and vascular resistance.
  • Pediatric PH, though less common, carries a significant mortality risk.
  • Existing research and registries aim to improve diagnosis, treatment, and overall understanding.

Conclusions:

  • A thorough understanding of PH definition, classification, epidemiology, prognosis, and treatment is crucial.
  • Continued research and data collection through registries are vital for advancing pediatric PH care.
  • Improved knowledge and management strategies are essential to reduce the high mortality associated with pediatric PH.

Keywords:
ChildDisease managementHypertension, pulmonaryIncidence

More Related Videos

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

6.9K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

954

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
902
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
611
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
611
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
688
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
815
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K